farnesol and Bladder Cancer

farnesol has been researched along with Bladder Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enokida, H; Miyamoto, K; Nakagawa, M; Osako, Y; Sakaguchi, T; Sugita, S; Yonemori, M; Yoshino, H	1

Other Studies

1 other study(ies) available for farnesol and Bladder Cancer

Article	Year
HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer. International journal of oncology, 2018, Volume: 53, Issue:2 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Farnesol; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Regulatory Networks; Glycolysis; Humans; Mice; Mutation; Oxidative Phosphorylation; Proteomics; Proto-Oncogene Mas; Proto-Oncogene Proteins p21(ras); Salicylates; Up-Regulation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays	2018

Article

Year

HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.

International journal of oncology, 2018, Volume: 53, Issue:2

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Farnesol; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Regulatory Networks; Glycolysis; Humans; Mice; Mutation; Oxidative Phosphorylation; Proteomics; Proto-Oncogene Mas; Proto-Oncogene Proteins p21(ras); Salicylates; Up-Regulation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2018